[1]
Malapelle, U., Buglioni, S., Castellano, I., Criscitiello, C., Curigliano, G., d’Amati, G., De Angelis, C., de Biase, D., Pepe, F., Perrone, G., Scatena, C., Scatolini, M., Trapani, D., Venetis, K. and Fusco, N. 2026. Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2− metastatic breast cancer. Pathologica - Journal of the Italian Society of Anatomic Pathology and Diagnostic Cytopathology. 117, 6 (Feb. 2026). DOI:https://doi.org/10.32074/1591-951X-1531.